Companies House 09411820 2026-03-31 2026-03-31 2025-04-01 false iso4217:GBP xbrli:pure 09411820 2024-04-01 2025-03-31 09411820 2026-03-31 09411820 2025-04-01 2026-03-31 09411820 2025-03-31 09411820 curr:PoundSterling 2025-04-01 2026-03-31 09411820 uk-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 09411820 uk-bus:FRS102 2025-04-01 2026-03-31 09411820 uk-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 09411820 uk-bus:FullAccounts 2025-04-01 2026-03-31 09411820 uk-bus:RegisteredOffice 2025-04-01 2026-03-31 09411820 uk-bus:Director1 2025-04-01 2026-03-31 09411820 uk-bus:Director2 2025-04-01 2026-03-31 09411820 uk-bus:Director3 2025-04-01 2026-03-31 09411820 uk-bus:Director4 2025-04-01 2026-03-31 09411820 uk-bus:Director5 2025-04-01 2026-03-31 09411820 uk-bus:Director6 2025-04-01 2026-03-31 09411820 uk-bus:Director7 2025-04-01 2026-03-31 09411820 uk-bus:Director8 2025-04-01 2026-03-31 09411820 uk-bus:Director9 2025-04-01 2026-03-31 09411820 uk-bus:Director10 2025-04-01 2026-03-31 09411820 uk-bus:Director11 2025-04-01 2026-03-31 09411820 uk-bus:Director12 2025-04-01 2026-03-31 09411820 uk-bus:Director13 2025-04-01 2026-03-31 09411820 uk-bus:Director14 2025-04-01 2026-03-31 09411820 uk-bus:Director15 2025-04-01 2026-03-31 09411820 uk-bus:Director16 2025-04-01 2026-03-31 09411820 uk-bus:Director17 2025-04-01 2026-03-31 09411820 uk-bus:Director18 2025-04-01 2026-03-31 09411820 uk-bus:Director19 2025-04-01 2026-03-31 09411820 uk-bus:Director20 2025-04-01 2026-03-31 09411820 uk-bus:Director21 2025-04-01 2026-03-31 09411820 uk-bus:CompanySecretary1 2025-04-01 2026-03-31 09411820 core:AfterOneYear 2026-03-31 09411820 core:AfterOneYear 2025-03-31 09411820 core:WithinOneYear 2026-03-31 09411820 core:WithinOneYear 2025-03-31 09411820 core:WithinOneYear 2025-04-01 2026-03-31 09411820 core:AfterOneYear 2026-03-31 09411820 core:AfterOneYear 2025-03-31 09411820 core:AfterOneYear 2025-04-01 2026-03-31 09411820 core:ShareCapital 2026-03-31 09411820 core:ShareCapital 2025-03-31 09411820 core:SharePremium 2026-03-31 09411820 core:SharePremium 2025-03-31 09411820 core:OtherReservesSubtotal 2026-03-31 09411820 core:OtherReservesSubtotal 2025-03-31 09411820 core:RevaluationReserve 2026-03-31 09411820 core:RevaluationReserve 2025-03-31 09411820 core:RetainedEarningsAccumulatedLosses 2026-03-31 09411820 core:RetainedEarningsAccumulatedLosses 2025-03-31 09411820 1 2025-04-01 2026-03-31 09411820 2 2025-04-01 2026-03-31 09411820 3 2025-04-01 2026-03-31 09411820 core:LandBuildings 2025-04-01 2026-03-31 09411820 core:LandBuildings 2026-03-31 09411820 core:LandBuildings 2024-04-01 2025-03-31 09411820 core:LandBuildings 2025-03-31 09411820 core:PlantMachinery 2025-04-01 2026-03-31 09411820 core:PlantMachinery 2026-03-31 09411820 core:PlantMachinery 2024-04-01 2025-03-31 09411820 core:PlantMachinery 2025-03-31 09411820 core:FurnitureFittingsToolsEquipment 2025-04-01 2026-03-31 09411820 core:FurnitureFittingsToolsEquipment 2026-03-31 09411820 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 09411820 core:FurnitureFittingsToolsEquipment 2025-03-31 09411820 core:OfficeEquipment 2025-04-01 2026-03-31 09411820 core:OfficeEquipment 2026-03-31 09411820 core:OfficeEquipment 2024-04-01 2025-03-31 09411820 core:OfficeEquipment 2025-03-31 09411820 core:Vehicles 2025-04-01 2026-03-31 09411820 core:Vehicles 2026-03-31 09411820 core:Vehicles 2024-04-01 2025-03-31 09411820 core:Vehicles 2025-03-31 09411820 core:NetGoodwill 2025-04-01 2026-03-31 09411820 core:NetGoodwill 2026-03-31 09411820 core:NetGoodwill 2024-04-01 2025-03-31 09411820 core:NetGoodwill 2025-03-31 09411820 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-03-31 09411820 core:IntangibleAssetsOtherThanGoodwill 2026-03-31 09411820 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 09411820 core:IntangibleAssetsOtherThanGoodwill 2025-03-31

# CLINICAL LEADERSHIP LIMITED

## Company Registration Number:
09411820 (England and Wales)

## Unaudited statutory accounts for the year ended 31 March 2026

## Period of accounts

## Start date: 1 April 2025

## End date: 31 March 2026

# CLINICAL LEADERSHIP LIMITED

## Contents of the Financial Statements

for the Period Ended 31 March 2026

Directors report |
Balance sheet |
Additional notes |
Balance sheet notes |

# CLINICAL LEADERSHIP LIMITED

Directors' report period ended 31 March 2026

The directors present their report with the financial statements of the company for the period ended 31 March 2026

Directors

The directors shown below have held office during the whole of the period from
1 April 2025 to 31 March 2026

Dr Lisa Jane Harrod-Rothwell
Mr Daniel Jonathan Rothwell

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
14 July 2026

And signed on behalf of the board by:
Name: Dr Lisa Jane Harrod-Rothwell
Status: Director

# CLINICAL LEADERSHIP LIMITED

## Balance sheet

As at 31 March 2026

| Notes | 2026 | 2025
--- | --- | --- | ---
|  | £ | £
Current assets
Cash at bank and in hand: |  | 494 | 494
Total current assets: |  | 494 | 494
Creditors: amounts falling due within one year: | 3 | ( 264 ) | ( 54 )
Net current assets (liabilities): |  | 230 | 440
Total assets less current liabilities: |  | 230 | 440
Total net assets (liabilities): |  | 230 | 440
Capital and reserves
Called up share capital: |  | 2 | 2
Profit and loss account: |  | 228 | 438
Total Shareholders' funds: |  | 230 | 440

The notes form part of these financial statements

# CLINICAL LEADERSHIP LIMITED

## Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 14 July 2026
and signed on behalf of the board by:

Name: Dr Lisa Jane Harrod-Rothwell
Status: Director

The notes form part of these financial statements

# CLINICAL LEADERSHIP LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# CLINICAL LEADERSHIP LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

- ## 2. Employees

  | 2026 | 2025
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# CLINICAL LEADERSHIP LIMITED

## Notes to the Financial Statements

for the Period Ended 31 March 2026

## 3. Creditors: amounts falling due within one year note

| 2026 | 2025
--- | --- | ---
| £ | £
Accruals and deferred income | 210 |
Other creditors | 54 | 54
Total | 264 | 54